We successfully presented our innovation at LSI USA, joining a distinguished community of global leaders and innovators shaping the future of healthcare. Our CEO, Ioanna Zergioti, delivered a compelling presentation, showcasing our transformative technology and vision. We were delighted to connect with investors, strategic partners, and fellow pioneers, and we look forward to building on these valuable interactions. READ MORE

March 20, 2026 PhosPrint successfully completed its technical visits within the NEOLIVER project, achieving the first official installation of its GEN1 laser bioprinter outside the company.The system is now fully operational at DWI – Leibniz Institute for Interactive Materials in Aachen, supporting advanced bioprinting research and collaboration.This milestone strengthens the joint effort toward developing the world’s first autologous bioprinted liver and enhances the reprodu

Our CEO, Ioanna Zergioti, participated in the Women Forum Summit, organized by the SEV Hellenic Federation of Enterprises, alongside distinguished female leaders. The panel focused on the role of women in innovation and technology, offering valuable insights and perspectives. We are proud to contribute to this important dialogue and support the advancement of female leadership in these fields. https://www.linkedin.com/posts/phosprint-p-c_women-forward-summit-powered-by-sev-ac

Στην πλέον κρίσιμη καμπή της πορείας της εισέρχεται η PhosPrint, καθώς έλαβε το "πράσινο φως” για την έναρξη της πρώτης κλινικής δοκιμής, μετά την ολοκλήρωση seed γύρου χρηματοδότησης ύψους 500.000 ευρώ από το Corallia Ventures TT και τον συνιδρυτή του Google Maps, Lars Rasmussen. Η επένδυση θα στηρίξει την πρώτη κλινική δοκιμή σε άνθρωπο της πλατφόρμας InvivoLPrint-U, του πρώτου διεθνώς βιοεκτυπωτή που έχει σχεδιαστεί για να ανακατασκευάζει ιστό ουροδόχου κύστης απευθείας στ

Η PhosPrint έχει προσελκύσει το ενδιαφέρον ελληνικών μέσων ενημέρωσης για την καινοτόμο τεχνολογία in vivo βιοεκτύπωσης ουροδόχου κύστης. Δημοσιεύματα αναδεικνύουν τον InvivoLPrint-U , τον πρώτο παγκοσμίως βιοεκτυπωτή που επιτρέπει την άμεση εκτύπωση αυτόλογων κυττάρων κατά τη διάρκεια χειρουργικής επέμβασης, καθώς και την πρόσφατη επένδυση που στηρίζει την πρώτη κλινική εφαρμογή σε άνθρωπο. PhosPrint has attracted media attention for its innovative in vivo bladder bio-printi

It is a great honor for us to have completed this first funding round with our investors, Corallia Ventures and Lars Rasmussen . We sincerely thank them for their trust and belief in our vision to develop innovative, tissue bioprinting–based solutions to address unmet medical needs and improve the quality of life for thousands of patients. https://lnkd.in/eRxJbMVN

We’re proud to announce that we’ve been selected to pitch our solution at Europe’s leading platform for HealthTech innovation and investment — the HealthTech Investor Summit, taking place 8–10 December 2025 in Utrecht. For three days, we’ll be joining innovators, investors, and industry experts to exchange ideas, explore partnerships, and unlock new funding opportunities. Read more

A big thank-you to PRAXI Network and Brookstreet Equity Partners LLP for the ConnectingTheDots initiative and for highlighting the strength of Greek innovation. At PhosPrint, we’re bringing Laser BioPrinting and regenerative medicine closer to the patient — providing research teams and tools for targeted tissue therapies. We’re proud of our progress and excited for the next steps in London on 14 November 2025. Many thanks to the organizers, judges, and community for their tru

We are pleased to announce that Ioanna Zergioti, CEO of PhosPrint P.C., has been elected Vice President of the Photonics21 Executive Board during the annual meeting held on May 15–16 in Brussels. ​ PhosPrint is an active member of the Board of Stakeholders of Photonics21, the European Technology Platform that brings together over 3,800 leading photonics companies, research organizations, and innovation players across Europe. ​ Ioanna Zergioti’s appointment highlights her sign

We are excited to share that our company was selected to participate in the HIAS Entrepreneurship Workshop 2025, hosted by the Hellenic Institute of Advanced Studies. This prestigious event brought together some of the most promising and innovative startups in Greece. ​ Our Co-Founder and CEO, Ioanna Zergioti, had the honor of presenting our latest technologies and solutions to a distinguished audience, alongside an inspiring group of fellow startup founders. The workshop fos

CEO Dr. Ioanna Zergioti participated as a panelist in a high-level discussion organized by the Athens Chamber of Commerce and Industry (ΕΒΕΑ - ACCI), under the presidency of Ms. Sophia Efraimoglou-Kounenaki, and moderated by Dr. Eleni Episkopou. The discussion focused on Europe’s role in shaping the global future of biotechnology and medical technology — from artificial intelligence to bioprinting — with ethics and equity at the center of innovation. The panel also highlighte

We are thrilled and very proud to be included in the Tech Awards Gala 2024 #WTA2024 in Berlin, as one of the 3 Top Finalists in the...

On February 26th our CEO Dr Ioanna Zergioti participated in the “Female Startup Founders: Funding Innovative Investments” event, co-organized by ICC Women Hellas Finance cluster headed by Giota Stathakou and Startups cluster headed by Maria Hala. The event hosted other dynamic Greek female founders and investors and was also attended by Ministers Niki Kerameus, Minister of Labour and Social Insurance, and Zoe Rapti Deputy Minister of Development. ​ Female investors panelists